Merck researchers privately sought to alter Vioxx in 2000 to reduce its cardiovascular side effects, even as the drug maker publicly downplayed a study on potential heart attack risk. That's according to a company document mistakenly given to plaintiffs lawyers for one of the many Vioxx lawsuits around the country. The document is potentially among the most damaging to emerge since drug sales were suspended because it calls into question Merck's defense that officials were convinced of Vioxx's safety.
June 23, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Sellars, Marion, Bachi & Contri, P.A., a well-established civil defense law firm with over 30 years of experience in West Palm Beach, Fl...
Mineola defense firm seeks attorneys with 3-5 years of actual insurance defense experience to handle complex general liability matters. Sala...
Pacific Law Partners, LLP Seeking Litigation Associate Attorney with 3+ years relevant experience Recognized for decades as specialists i...